Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 11, 2015 - Issue 1
Submit an article Journal homepage
1,415
Views
7
CrossRef citations to date
0
Altmetric
Research Paper

Safety and tolerability of 13-valent pneumococcal conjugate vaccine in the elderly

An observational study in Liguria Region, Italy

Paolo Durando Department of Health Sciences, Vaccines and Clinical Trials Unit; University of Genoa, Italy; I.R.C.C.S. A.O.U. San Martino - IST of Genoa; Italy and Integrated Group for the Development of Vaccine Sciences (GISVa); Genoa, ItalyCorrespondence[email protected]
,
Roberto Rosselli Hygiene and Public Health Unit; Local Health Unit 3 of Genoa; Italy and Integrated Group for the Development of Vaccine Sciences (GISVa); Genoa, Italy
,
Ilaria Cremonesi Department of Health and Social Services; Prevention, Public Health and Vulnerable Social Groups; Liguria Region, Italy
,
Andrea Orsi Department of Health Sciences, Vaccines and Clinical Trials Unit; University of Genoa, Italy; I.R.C.C.S. A.O.U. San Martino - IST of Genoa; Italy and Integrated Group for the Development of Vaccine Sciences (GISVa); Genoa, Italy
,
Erika Albanese Department of Health Sciences, Vaccines and Clinical Trials Unit; University of Genoa, Italy; I.R.C.C.S. A.O.U. San Martino - IST of Genoa; Italy and Integrated Group for the Development of Vaccine Sciences (GISVa); Genoa, Italy
,
Ilaria Barberis Department of Health Sciences, Vaccines and Clinical Trials Unit; University of Genoa, Italy; I.R.C.C.S. A.O.U. San Martino - IST of Genoa; Italy and Integrated Group for the Development of Vaccine Sciences (GISVa); Genoa, Italy
,
Chiara Paganino Department of Health Sciences, Vaccines and Clinical Trials Unit; University of Genoa, Italy; I.R.C.C.S. A.O.U. San Martino - IST of Genoa; Italy and Integrated Group for the Development of Vaccine Sciences (GISVa); Genoa, Italy
,
Cecilia Trucchi Department of Health Sciences, Vaccines and Clinical Trials Unit; University of Genoa, Italy; I.R.C.C.S. A.O.U. San Martino - IST of Genoa; Italy and Integrated Group for the Development of Vaccine Sciences (GISVa); Genoa, Italy
,
Mariano Martini Department of Health Sciences, Vaccines and Clinical Trials Unit; University of Genoa, Italy; I.R.C.C.S. A.O.U. San Martino - IST of Genoa; Italy and Integrated Group for the Development of Vaccine Sciences (GISVa); Genoa, Italy
,
Lorenzo Marensi Hygiene and Public Health Unit; Local Health Unit 3 of Genoa; Italy and Integrated Group for the Development of Vaccine Sciences (GISVa); Genoa, Italy
,
Valter Turello Hygiene and Public Health Unit; Local Health Unit 3 of Genoa; Italy and Integrated Group for the Development of Vaccine Sciences (GISVa); Genoa, Italy
,
the Ligurian Pneumococcal Study Group
,
Alessandro Bregante
,
Roberto Cacciani
,
Rocco Iudici
,
Diego La Marca
,
Leonardo Pedano
,
Amadio Franco Petrucci
,
Maria Santolini
,
Valentina Sbisà
&
Monica Zacconi
 show all
Pages 172-177 | Received 18 Jul 2014, Accepted 26 Jul 2014, Published online: 01 Nov 2014

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jerome Ateudjieu, Beat Stoll, Anne Cecile Bisseck, Ayok M. Tembei & Blaise Genton. (2020) Safety profile of the meningococcal conjugate vaccine (Menafrivac™) in clinical trials and vaccination campaigns: a review of published studies. Human Vaccines & Immunotherapeutics 16:6, pages 1245-1259.
Read now

Articles from other publishers (6)

Noriko MATSUMOTOMasayuki OHKURABennett LEETomoyuki HAYAMIZU. (2022) Safety of A Pneumococcal 13-valent Conjugate Vaccine in Elderly Japanese Patients in Daily Practice: Results of A Drug Use-Results Survey高齢者に対する沈降13価肺炎球菌結合型ワクチンの日常診療下における安全性評価―使用成績調査―. Kansenshogaku Zasshi 96:1, pages 15-24.
Crossref
Heather L. Platt, Jose F. Cardona, Miwa Haranaka, Howard I. Schwartz, Silvia Narejos Perez, Anthony Dowell, Chih-Jen Chang, Ron Dagan, Gretchen M. Tamms, Tina Sterling, Leslie Morgan, Yaru Shi, Alison Pedley, Luwy K. Musey & Ulrike K. Buchwald. (2022) A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE). Vaccine 40:1, pages 162-172.
Crossref
Donald Hurley, Carl Griffin, Mariano YoungJrJr, Daniel A Scott, Michael W Pride, Ingrid L Scully, John Ginis, Joseph Severs, Kathrin U Jansen, William C Gruber & Wendy Watson. (2021) Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age. Clinical Infectious Diseases 73:7, pages e1489-e1497.
Crossref
Almea Matanock, Grace Lee, Ryan Gierke, Miwako Kobayashi, Andrew Leidner & Tamara Pilishvili. (2019) Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices. MMWR. Morbidity and Mortality Weekly Report 68:46, pages 1069-1075.
Crossref
Penina Haber, Jorge Arana, Tamara Pilishvili, Paige Lewis, Pedro L. Moro & Maria Cano. (2016) Post-licensure surveillance of 13-valent pneumococcal conjugate vaccine (PCV13) in adults aged ⩾19years old in the United States, Vaccine Adverse Event Reporting System (VAERS), June 1, 2012–December 31, 2015. Vaccine 34:50, pages 6330-6334.
Crossref
K.M. Damer & C.M. Jung. 2016. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions 307 334 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.